subject: The new medical reform contribute to the eradication area of chronic illness, drug sales - healthcar [print this page] The new medical reform contribute to the eradication area of chronic illness, drug sales - healthcar
Medicine Buying and selling in the field of misconduct, has been the focus of national strikes. On November 20 last year, the Supreme People's Procuratorate issued the "on the handling of criminal cases of commercial bribery law applicable to the views of a number of issues," an official from the law defines the level of drug sales in the field of kickbacks and other acts of illegality. However, this is not possible to fundamentally prevent sales of medicines in the field of misconduct. New Medical reform The introduction, let us see the whole field of medicine purchases and sales may be purified. The new medical reform is a complicated systematic project, the cleaning industry is a complex of measures, together, the more the core content of the following:
"Two votes" system and the "slip flow" of the management and control
To regulate and promote the new situation, centralized purchasing medical drugs, and many other ministries by the Ministry of Health, "signed to further regulate the Drug centralized purchasing of medical opinion" (the "Opinion") before the Spring Festival this year published. "Opinion" includes seven aspects, including a little on drugs Proxy Business impact of large, namely: "centralized drug purchasing by the wholesale companies to bid directly to drug manufacturers bidding. Or consigned by the manufacturer with the ability of pharmaceutical management of modern logistics enterprises to direct distribution of medical institutions, in principle, allow the commission only once. If Enterprises can not be entrusted to the direct delivery of medical institutions, the centralized procurement of drugs by the provincial regulatory approval, may appoint other corporate distribution. "This is actually the original Guangdong three years ago," two votes "system, in operation part of the implementation of the the "three votes", so "opinions" of the policy-making more flexible.
Recently, the "Measures for the Administration of drug prices" (draft) spread out from informal channels, which includes Health Conference in Guangdong late last year to set and debug line drug price control "three control" policies (simultaneous control of the retail price wholesale price and circulation slip). The current retail price has been strictly controlled "circulation slip" in control, the tightly grabbed the agent's throat, "reserve price" behavior of the commodity will be gone forever.
These two policies are aimed at reducing circulation and inhibit "layers increases," rationalize the commercial flow of drugs. Current sense, the agent will disappear, they will be dependent on pharmaceutical companies to collect a "commission", can be regarded as employees of pharmaceutical companies, all responsibilities can be traced back to pharmaceutical companies. Therefore, the "two-vote" and "slip flow" and other price control system would force pharmaceutical companies conduct binding agents to enhance Marketing Level.
Government investment and the doctors "practice more"
Country into a long-term shortage of medical and health services, resulting in a lot of "medicine, regardless of" defects, which is the field of commercial bribery, drug sales frequently the root causes of the incident. 3-year national commitment to the cause of 850 billion yuan into the medical and health, which will help doctors to increase the income of this group overall. "More practice," the legalization could also play a role. Relax the doctor, so that a high level of medical doctors with their own skills through "more practice" reasonable compensation in line with the spirit of the new medical reform, in line with the needs of the times.
When the state has invested directly or indirectly to enhance the medical income, the doctors kickbacks for drugs will reduce the degree of attention on the gray income weakening demand. Whether the extent of weakening demand for the purification of a positive role in drug sales in the field.
